COMMUNIQUÉS West-GlobeNewswire

Gefion Group Investments A/S provisionally extends offer period
25/06/2018
Company announcement 25 June 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
Scapa Healthcare Closed Fiscal Year with Significant Enhancements of Capabilities and Technologies
25/06/2018
Expanded North American Manufacturing Footprint through an Acquisition and New Manufacturing Site WINDSOR, Conn., June 25, 2018 (GLOBE NEWSWIRE) -- Scapa Healthcare , a trusted strategic outsource partner of skin [...]
Align Technology Reaches One Millionth Invisalign(R) Patient in the EMEA Region
25/06/2018
Milestone Reflects Accelerating Adoption of Invisalign Treatment Among Adults and Teens in Europe SAN JOSE, Calif. and AMSTERDAM, The Netherlands, June 25, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq:ALGN), [...]
“Grindeks” completes acquisition of “HBM Pharma” s.r.o.
25/06/2018
JSC “Grindeks” announces completion of acquisition of 100% shares of “HBM Pharma” s.r.o. (Slovakia) from “Dashdirect Limited” (Cyprus) as of June 21, 2018. The total contract amount was 18.2 million euro and JSC “ [...]
ViroGates A/S: Registration of capital increase and admission to trading
25/06/2018
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN. This announcement does not constitute a prospectus. No one [...]
MannKind Set to Join Russell 3000® Index
25/06/2018
WESTLAKE VILLAGE, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such [...]
La Jolla Pharmaceutical Company Announces European Medicines Agency Validation of Marketing Authorisation Application for GIAPREZA™ (angiotensin II)
25/06/2018
SAN DIEGO, June 25, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq:LJPC), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes [...]
BlissCo Executing Its Plan, Oils and Extracts Up Next -- CFN Media
25/06/2018
SEATTLE, June 25, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Microbot Medical Strengthens Global IP with Issued Patent in India Covering the Company’s ViRob™ Technology Platform
25/06/2018
HINGHAM, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq CM:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical technologies, today [...]
High Hampton Expands Strategic Network in California -- CFN Media
25/06/2018
SEATTLE, June 25, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]
ORYZON announces First Patients in the UK in ETHERAL: a Phase IIa clinical trial in Alzheimer’s Disease with ORY-2001
25/06/2018
MADRID, Spain and CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Oryzon Genomics (ISIN Code:ES0167733015) (BME:ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in [...]
Marrone Bio Innovations Joins the Russell 2000 Index
25/06/2018
DAVIS, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and [...]
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares
25/06/2018
FIT Biotech Oy Company release June 25, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]
Vericel Added to Russell 3000® Index
25/06/2018
CAMBRIDGE, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that it has been added to [...]
International Endeavors to Open Showroom in Las Vegas
25/06/2018
TEMECULA, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Plans are underway for International Endeavors Corporation (OTC: IDVV) to open a showroom in Las Vegas to demonstrate the Off Grid Grow Laboratory ( [...]
Albireo Added to Russell 2000® Index
25/06/2018
BOSTON, June 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that it has been added to the [...]
Peer Reviewed Results: Conformis Patient Specific iTotal CR Achieves Better Rotational Alignment and Tibial Fit Compared to Off-the-Shelf Implants
25/06/2018
Manuscript highlights the intraoperative compromises of fit vs. rotation with the legacy off-the-shelf knee implants BILLERICA, Mass., June 25, 2018 (GLOBE NEWSWIRE) -- Conformis Inc. (NASDAQ:CFMS), a medical technology [...]
Portola Pharmaceuticals Appoints 30-Year Industry Veteran Glenn Brame as Senior Vice President of Technical Operations
25/06/2018
SOUTH SAN FRANCISCO, Calif., June 25, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq:PTLA) today announced the appointment of Glenn Brame as senior vice president of technical operations, effective [...]
Progenics Pharmaceuticals Presents Data Validating its Artificial Intelligence Imaging Analysis Technology for Use with PSMA-Targeted SPECT/CT
25/06/2018
Algorithm Validated Using Data from Company's 1404 Phase 2 Study NEW YORK, June 25, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging [...]

Pages